- Report
- December 2023
- 80 Pages
United States
From €1466EUR$1,500USD£1,224GBP
- Report
- December 2023
- 80 Pages
Vietnam
From €1466EUR$1,500USD£1,224GBP
- Report
- December 2023
- 100 Pages
Africa
From €1954EUR$2,000USD£1,631GBP
- Report
- December 2023
- 80 Pages
Brazil
From €1466EUR$1,500USD£1,224GBP
- Report
- November 2024
- 115 Pages
United States
From €2438EUR$2,495USD£2,035GBP
- Report
- September 2024
- 116 Pages
United States
From €2438EUR$2,495USD£2,035GBP
- Report
- March 2024
- 132 Pages
Global
From €928EUR$950USD£775GBP
- Report
- January 2024
- 132 Pages
Global
From €928EUR$950USD£775GBP
- Report
- November 2023
- 56 Pages
China
From €1759EUR$1,800USD£1,468GBP
- Report
- November 2023
- 108 Pages
China
From €1759EUR$1,800USD£1,468GBP
- Report
- November 2023
- 220 Pages
China
From €3908EUR$4,000USD£3,263GBP
From €4397EUR$4,500USD£3,671GBP
- Report
- April 2022
Global
From €9282EUR$9,500USD£7,749GBP
- Report
- October 2021
Global
From €9282EUR$9,500USD£7,749GBP
- Report
- June 2023
- 252 Pages
Global
From €3488EUR$3,570USD£2,912GBP
- Book
- December 2020
- 432 Pages
- Book
- January 2018
- 310 Pages
The Generic Drugs market is a segment of the pharmaceutical industry that focuses on the production and sale of generic drugs. Generic drugs are copies of brand-name drugs that have the same active ingredients, dosage form, strength, route of administration, safety, efficacy, and intended use as the original drug. Generic drugs are typically much cheaper than their brand-name counterparts, making them a popular choice for consumers.
Generic drugs are produced by a variety of companies, including large pharmaceutical companies, small generic drug manufacturers, and even generic drug divisions of brand-name drug companies. Generic drug companies must meet the same standards of quality, safety, and efficacy as brand-name drug companies.
Some of the major companies in the Generic Drugs market include Teva Pharmaceuticals, Mylan, Sandoz, Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Lupin. Show Less Read more